Shanghai Pharmaceuticals Holding Co., Ltd (SHA: 601607)
China flag China · Delayed Price · Currency is CNY
20.91
+0.20 (0.97%)
Nov 19, 2024, 3:00 PM CST

Shanghai Pharmaceuticals Holding Revenue

Shanghai Pharmaceuticals Holding had revenue of 70.22B CNY in the quarter ending September 30, 2024, with 8.16% growth. This brings the company's revenue in the last twelve months to 272.42B, up 6.88% year-over-year. In the year 2023, Shanghai Pharmaceuticals Holding had annual revenue of 260.30B with 12.21% growth.

Revenue (ttm)
272.42B
Revenue Growth
+6.88%
P/S Ratio
0.30
Revenue / Employee
5.66M
Employees
48,164
Market Cap
72.46B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023260.30B28.31B12.21%
Dec 31, 2022231.98B16.16B7.49%
Dec 31, 2021215.82B23.92B12.46%
Dec 31, 2020191.91B5.34B2.86%
Dec 31, 2019186.57B27.48B17.27%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition